Vanda Pharmaceuticals, Inc. (VNDA)
8.81
-0.48
(-5.17%)
USD |
NASDAQ |
Mar 13, 16:00
8.86
+0.05
(+0.57%)
After-Hours: 20:00
Vanda Pharmaceuticals Market Cap : 520.74M for March 13, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 879.67B |
| Gilead Sciences, Inc. | 179.99B |
| Axsome Therapeutics, Inc. | 7.984B |
| Gossamer Bio, Inc. | 101.17M |
| Arcellx, Inc. | 6.690B |
Market Cap Related Metrics
| PS Ratio | 2.402 |
| PEG Ratio | -0.0022 |
| Price to Book Value | 1.592 |
| Price | 8.81 |
| Earnings Yield | -42.41% |
| PEGY Ratio | -0.0022 |